openPR Logo
Press release

New Research Report on Peptide Based Cardiovascular Therapeutics Market , 2018-2028

02-18-2019 11:14 AM CET | Business, Economy, Finances, Banking & Insurance

Press release from: Fact.MR

/ PR Agency: Fact.MR
Peptide Based Cardiovascular Therapeutics

Peptide Based Cardiovascular Therapeutics

This Fact.MR report on the global peptide based cardiovascular therapeutics market forecasts that the global peptide based cardiovascular therapeutics market will touch a value of nearly US$ 1,960 Mn in the year 2022 and grow at a robust CAGR during the assessment period.

North America Market Set to Dominate the Global Peptide Based Cardiovascular Therapeutics Market in Terms of Revenue

The market in North America is set to dominate the global peptide based cardiovascular therapeutics market in terms of value and this trend is projected to sustain itself throughout the assessment period. North America peptide based cardiovascular therapeutics market is the most attractive market, growing at a robust CAGR over the assessment period.

Request Sample Report @ https://www.factmr.com/connectus/sample?flag=S&rep_id=191

Bivalirudin Segment Poised to Touch a Value of Nearly US$ 1,360 Mn in 2022

As per the forecast of Fact.MR, the bivalirudin segment is expected to reach a value of nearly US$ 1,360 Mn in the year 2022. This represents a robust CAGR during the forecast period of 2017-2022. Bivalirudin segment is expected to account for more than two-third of the revenue share of the drug segment by the year 2017 and is expected to lose market share by the end of the year 2022.

Hospital Pharmacies Segment to exhibit a CAGR of 8.9% During the Assessment Period

As per the forecast of Fact.MR, the hospital pharmacies segment is slated to touch a figure of nearly US$ 960 Mn in the year 2022. This represents a CAGR of 8.9% during the assessment period from 2017 till the year 2022. This segment is expected to lose market share by the end of the year 2022. The hospital pharmacies segment is expected to account for more than half of the revenue share of the distribution channel segment by the year 2017.

Request/View Toc@ https://www.factmr.com/connectus/sample?flag=T&rep_id=191

Competition Tracking

The report also profiles companies that are expected to remain active in the expansion of global peptide based cardiovascular therapeutics market through 2022, which include AstraZeneca, plc, Corden Pharma GmbH, Ipsen S.A, Merck & Co., Inc., Pfizer Inc, Apotex Holdings, Inc., Dr. Reddy's Laboratories Limited, Fresenius Kabi USA, LLC, Novetide Ltd and Amneal Pharmaceuticals LLC.

Therapeutic peptides are used in the treatment of cardiovascular disorders that are a leading cause of mortality and morbidity throughout the world. Peptides are short chains of amino acid monomers linked by peptide (amide) bonds. Such type of covalent chemical bonds are formed when the carboxyl group of one amino acid reacts with the amino group of another. Peptides are differentiated from proteins on the basis of size, and peptides contain 50 amino acids or less approximately.

Speak To Research Analyst for Detailed Insights @ https://www.factmr.com/connectus/sample?flag=AE&rep_id=191

Detailed TOC of Global Peptide Based Cardiovascular Therapeutics Market by Manufacturers, Regions, Type and Application, Forecast to 2022

1. Global Peptide Based Cardiovascular Therapeutics Market - Executive Summary

2. Global Peptide Based Cardiovascular Therapeutics Market Overview
2.1. Introduction
2.1.1. Global Peptide Based Cardiovascular Therapeutics Market Taxonomy
2.1.2. Global Peptide Based Cardiovascular Therapeutics Market Definition
2.2. Global Peptide Based Cardiovascular Therapeutics Market Size (US$ Mn) and Forecast, 2012-2022
2.2.1. Global Peptide Based Cardiovascular Therapeutics Market Y-o-Y Growth
2.3. Global Peptide Based Cardiovascular Therapeutics Market Dynamics
2.4. Regulations
2.5. Supply Chain
2.6. Cost Structure
2.7. Average Pricing Analysis
2.8. Epidemiology
2.9. Key Participants Market Presence (Intensity Map) By Region

Access This Report @ https://www.factmr.com/checkout/191/S

3. Global Peptide Based Cardiovascular Therapeutics Market Analysis and Forecast By Drug
3.1. Global Peptide Based Cardiovascular Therapeutics Market Size and Forecast By Drug, 2012-2022
3.1.1. Bivalirudin Peptide Based Cardiovascular Therapeutics Market Size and Forecast, 2012-2022
3.1.1.1. Revenue (US$ Mn) Comparison, By Region
3.1.1.2. Market Share Comparison, By Region
3.1.1.3. Y-o-Y growth Comparison, By Region
3.1.2. Eptifibatide Peptide Based Cardiovascular Therapeutics Market Size and Forecast, 2012-2022
3.1.2.1. Revenue (US$ Mn) Comparison, By Region
3.1.2.2. Market Share Comparison, By Region
3.1.2.3. Y-o-Y growth Comparison, By Region

4. Global Peptide Based Cardiovascular Therapeutics Market Analysis and Forecast By Distribution Channel
4.1. Global Peptide Based Cardiovascular Therapeutics Market Size and Forecast By Distribution Channel, 2012-2022
4.1.1. Hospital Pharmacies Peptide Based Cardiovascular Therapeutics Market Size and Forecast, 2012-2022
4.1.1.1. Revenue (US$ Mn) Comparison, By Region
4.1.1.2. Market Share Comparison, By Region
4.1.1.3. Y-o-Y growth Comparison, By Region
4.1.2. Retail Pharmacies Peptide Based Cardiovascular Therapeutics Market Size and Forecast, 2012-2022
4.1.2.1. Revenue (US$ Mn) Comparison, By Region
4.1.2.2. Market Share Comparison, By Region
4.1.2.3. Y-o-Y growth Comparison, By Region
4.1.3. Online Pharmacies Peptide Based Cardiovascular Therapeutics Market Size and Forecast, 2012-2022
4.1.3.1. Revenue (US$ Mn) Comparison, By Region
4.1.3.2. Market Share Comparison, By Region
4.1.3.3. Y-o-Y growth Comparison, By Region

5. Global Peptide Based Cardiovascular Therapeutics Market Analysis and Forecast By Region
5.1. Global Peptide Based Cardiovascular Therapeutics Market Size and Forecast, 2012-2022
5.1.1. North America Peptide Based Cardiovascular Therapeutics Market Size and Forecast, 2012-2022
5.1.1.1. Revenue (US$ Mn) Comparison, By Drug
5.1.1.2. Revenue (US$ Mn) Comparison, By Distribution Channel
5.1.2. Latin America Peptide Based Cardiovascular Therapeutics Market Size and Forecast, 2012-2022
5.1.2.1. Revenue (US$ Mn) Comparison, By Drug
5.1.2.2. Revenue (US$ Mn) Comparison, By Distribution Channel
5.1.3. Europe Peptide Based Cardiovascular Therapeutics Market Size and Forecast, 2012-2022
5.1.3.1. Revenue (US$ Mn) Comparison, By Drug
5.1.3.2. Revenue (US$ Mn) Comparison, By Distribution Channel
5.1.4. Japan Peptide Based Cardiovascular Therapeutics Market Size and Forecast, 2012-2022
5.1.4.1. Revenue (US$ Mn) Comparison, By Drug
5.1.4.2. Revenue (US$ Mn) Comparison, By Distribution Channel
5.1.5. APEJ Peptide Based Cardiovascular Therapeutics Market Size and Forecast, 2012-2022
5.1.5.1. Revenue (US$ Mn) Comparison, By Drug
5.1.5.2. Revenue (US$ Mn) Comparison, By Distribution Channel
5.1.6. MEA Peptide Based Cardiovascular Therapeutics Market Size and Forecast, 2012-2022
5.1.6.1. Revenue (US$ Mn) Comparison, By Drug
5.1.6.2. Revenue (US$ Mn) Comparison, By Distribution Channel

And Contnue...

List of Figures, Tables and Charts Available in Global Peptide Based Cardiovascular Therapeutics Market 2017 by Manufacturers, Regions, Type and Application, Forecast to 2022

TABLE 1 Global Peptide Based Cardiovascular Therapeutics Market Value (US$ Mn), 2012-2016

TABLE 2 Global Peptide Based Cardiovascular Therapeutics Market Value (US$ Mn), 2017-2022
TABLE 3 Global Peptide Based Cardiovascular Therapeutics Market Value (US$ Mn) and Y-o-Y, 2015-2022
TABLE 4 Global Bivalirudin Segment Value (US$ Mn), By Region 2012-2016
TABLE 5 Global Bivalirudin Segment Value (US$ Mn), By Region 2017-2022
TABLE 6 Global Bivalirudin Segment Market Share, By Region 2012-2016
TABLE 7 Global Bivalirudin Segment Market Share, By Region 2017-2022
TABLE 8 Global Bivalirudin Segment Y-o-Y, By Region 2015-2022
TABLE 9 Global Eptifibatide Segment Value (US$ Mn), By Region 2012-2016
TABLE 10 Global Eptifibatide Segment Value (US$ Mn), By Region 2017-2022
TABLE 11 Global Eptifibatide Segment Market Share, By Region 2012-2016
TABLE 12 Global Eptifibatide Segment Market Share, By Region 2017-2022
TABLE 13 Global Eptifibatide Segment Y-o-Y, By Region 2015-2022
TABLE 14 Global Hospital Pharmacies Segment Value (US$ Mn), By Region 2012-2016
TABLE 15 Global Hospital Pharmacies Segment Value (US$ Mn), By Region 2017-2022

And Continue...

FIG. 1 Global Peptide Based Cardiovascular Therapeutics Market Value (US$ Mn), 2012-2016
FIG. 2 Global Peptide Based Cardiovascular Therapeutics Market Value (US$ Mn) Forecast, 2017-2022
FIG. 3 Global Peptide Based Cardiovascular Therapeutics Market Value (US$ Mn) and Y-o-Y, 2015-2022
FIG. 4 Global Bivalirudin Segment Market Value (US$ Mn) By Region, 2012-2016
FIG. 5 Global Bivalirudin Segment Market Value (US$ Mn) By Region, 2017-2022
FIG. 6 Global Bivalirudin Segment Y-o-Y Growth Rate, By Region, 2015-2022
FIG. 7 Global Eptifibatide Segment Market Value (US$ Mn) By Region, 2012-2016
FIG. 8 Global Eptifibatide Segment Market Value (US$ Mn) By Region, 2017-2022
FIG. 9 Global Eptifibatide Segment Y-o-Y Growth Rate, By Region, 2015-2022
FIG. 10 Global Hospital Pharmacies Segment Market Value (US$ Mn) By Region, 2012-2016
FIG. 11 Global Hospital Pharmacies Segment Market Value (US$ Mn) By Region, 2017-2022
FIG. 12 Global Hospital Pharmacies Segment Y-o-Y Growth Rate, By Region, 2015-2022
FIG. 13 Global Retail Pharmacies Segment Market Value (US$ Mn) By Region, 2012-2016
FIG. 14 Global Retail Pharmacies Segment Market Value (US$ Mn) By Region, 2017-2022
FIG. 15 Global Retail Pharmacies Segment Y-o-Y Growth Rate, By Region, 2015-2022

And Continue...

About FactMR
FactMR is a fast-growing market research firm that offers the most comprehensive suite of syndicated and customized market research reports. We believe transformative intelligence can educate and inspire businesses to make smarter decisions. We know the limitations of the one-size-fits-all approach; that's why we publish multi-industry global, regional, and country-specific research reports.

Contact Us
FactMR
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Email: sales@factmr.com
Web: www.factmr.com/
Follow Us on Linkedin: www.linkedin.com/company/factmr/

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release New Research Report on Peptide Based Cardiovascular Therapeutics Market , 2018-2028 here

News-ID: 1595421 • Views: 131

More Releases from Fact.MR

11-09-2020 | Health & Medicine
Fact.MR
PCR and Real-time PCR Molecular Diagnostics Market to Surpass US$ 6 Bn by 2030, …
As per data from the World Health Organization, millions of deaths can be attributed to diseases such as cancer and HIV each year. Further, the recent outbreak of the COVID-19 virus has also created massive demand for effective diagnostics processes. The PCR and real-time PCR molecular diagnostics market has been gaining traction in recent years on the back of investments by PCR diagnostic test manufacturers towards the incorporation of molecular
10-05-2020 | Health & Medicine
Fact.MR
Biobanking Market to Soar to US$ 3.5 Bn by 2027, Notes Fact.MR
Biobanks are a type of repository which is used in the storage of biological samples, including human and animal tissues, which primarily find use in research applications. Consequently, the process of biobanking has become a very important part of medical research and has played a major role in modern science fields such as personalized medications, and genomics. The global biobanking market is expected to grow at a healthy CAGR of ~
Mini LED Market to Expand 7.5X by 2030, Finds New Study by Fact.MR
In recent years, increasing popularity of OLED TVs in China and India has been significantly influencing growth of the mini LED market. With an increase in disposable income of a majority of the population in these countries, the inclination towards smart screens with higher lifespan and better performance is expected to open up numerous growth opportunities for the mini LED market. Moreover, aspiring and affluent households have increased their spending
Uncertainty Surrounding COVID-19 to Shave-off Growth in Electrical Steel Market …
The global electrical steel market has utilized the opportunities in the market over the last decade with sales of electrical steel pegged at US$ 20.4 Bn in 2019. However, sales are set to plummet during in the middle two quarters of 2020 owing to COVID-19. In addition, several automakers have shuttered their production units, causing incalculable loss to the electrical steel market in 2020. However, the demand of electrical steel

All 5 Releases


More Releases for Region

US Men’s Underwear Market 2026 |Industry Key Regions : Northeast, West region, …
As the large amount of data is being generated everyday by companies all over the world, a new research study titled “Men’s Underwear Market: Increasing Number of Metrosexual Men in the U.S. Anticipated to Fuel Revenue Growth of the Boxer Shorts Segment During the Forecast Period: U.S. Industry Analysis and Opportunity Assessment, 2016-2026” has been generated and recently added into the vast database of Market Research Reports Search Engine (MRRSE).
Phenylbutazone Market Region-based Analysis by 2025
Global Phenylbutazone Market: Snapshot The phenylbutazone market has hit a road-block due to its disapproval from the country-wide market in the U.S. However, phenylbutazone, which are nonsteroidal anti-inflammatory drugs (NSAID) that are useful in treating pain, fever, menstrual cramps, arthritis, and other inflammations in human body, continue to be used in other parts of the World. Moreover, these drugs are also used by the veterinary department, wherein 23 actively marketed phenylbutazone
Gin Market Lucrative Segmentation by Region
Future Market Insights (FMI) delivers key insights on the India gin market in its latest report titled “Gin Market: India Industry Analysis and Opportunity Assessment, 2015 - 2025”. Revenue from the India gin market is anticipated to expand at a CAGR of 2.8% during the forecast period due to various factors, regarding which FMI offers fundamental insights in detail in this report. On the basis of product type, the market has
Hadoop Market Asia Pacific Most Lucrative Region
The vast shortage of data analysts capable of analyzing big data and the rising popularity of data analytics for uncovering unknown data correlations, hidden consumption patterns, market trends, and consumer preferences have strengthened the position of Hadoop in business circles in the past few years, points TMR. Hadoop is now considered an excellent substitute to human resources for effective data analysis and continues to expand its array of end-use industries. The
Somatostatin Market Manufacturers, Region, Application and Forecast
MRC announces the addition of new study based research report on Somatostatin market to their suite of offerings. Where the Somatostatin market is heading? If you are involved in Somatostatin sector, the report brings to your attention a basic overview of the Somatostatin market with market definition, classification, applications, segmentation, plans, manufacturing processes, product specifications, cost structures, regional analysis, and value chain analysis. Equipped with all vital stats and information
Asian Markets Bouncing Back Across the Region
Jul. 31, 2013 - HONG KONG -- Japan´s Nikkei Average is up 1.5%, breaking a four day losing streak that brought the average to a 30 day low. South Korea´s Kospi finished up almost 1% and the Shanghai Composite posted a minimal gain of 0.7% as did the Hang Seng in Hong Kong with a gain of 0.5%. The S&P /ASX 200 in Australia were down in morning trading, but